These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21044331)

  • 1. Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.
    Baston-Büst DM; Götte M; Janni W; Krüssel JS; Hess AP
    Reprod Biol Endocrinol; 2010 Nov; 8():133. PubMed ID: 21044331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the role of PGRMC2 in the human endometrium during the menstrual cycle and in vitro decidualization using an in vitro approach.
    Medina-Laver Y; Gonzalez-Martin R; de Castro P; Diaz-Hernandez I; Alama P; Quiñonero A; Palomar A; Dominguez F
    Hum Reprod; 2024 May; 39(5):1042-1056. PubMed ID: 38452349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosome dynamics during human endometrial stromal cells decidualization: effect of para-nonylphenol.
    Passaponti S; Manzan Martins C; Cresti L; Romagnoli R; Paulesu L; Ietta F; Ermini L
    Am J Physiol Cell Physiol; 2024 Jul; 327(1):C113-C121. PubMed ID: 38738312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired decidualization of human endometrial stromal cells from women with adenomyosis†.
    Peng Y; Jin Z; Liu H; Xu C
    Biol Reprod; 2021 May; 104(5):1034-1044. PubMed ID: 33533396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Role for the orphan nuclear receptor estrogen-related receptor alpha in endometrial stromal cell decidualization and expression of genes implicated in energy metabolism.
    Bombail V; Gibson DA; Collins F; MacPherson S; Critchley HO; Saunders PT
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E224-8. PubMed ID: 20668045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases.
    Zhang X; Zhao Y; Liu L; He Y
    Curr Drug Targets; 2023; 24(15):1155-1165. PubMed ID: 37957867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of metabolites from three vaginal bacteria on the Syndecan-1 of cervical epithelial cells.
    Xia Y; Feng Y; Jiang L; Heng Y; Li X; Ma C
    Heliyon; 2024 Jun; 10(12):e33426. PubMed ID: 39027438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of SDC-1 Gene Alleviates the Metabolic Pathway for the Development of MODS.
    Xie J; Ma Y; Huang Y; Wang Q; Xu Y; Zhang Q; Yang J; Yin W
    Mol Biotechnol; 2024 Aug; 66(8):1961-1969. PubMed ID: 37515659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia and hyperglycemia induce overexpression of Syndecan-3 in erythrocytes and modulate erythrocyte adhesion.
    Mallanna SH; Thimmulappa RK; Chilkunda ND
    J Biochem; 2024 Jul; ():. PubMed ID: 38960390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate.
    Vidal-Calvo EE; Martin-Salazar A; Choudhary S; Dagil R; Raghavan SSR; Duvnjak L; Nordmaj MA; Clausen TM; Skafte A; Oberkofler J; Wang K; Agerbæk MØ; Løppke C; Jørgensen AM; Ropac D; Mujollari J; Willis S; Garcias López A; Miller RL; Karlsson RTG; Goerdeler F; Chen YH; Colaço AR; Wang Y; Lavstsen T; Martowicz A; Nelepcu I; Marzban M; Oo HZ; Ørum-Madsen MS; Wang Y; Nielsen MA; Clausen H; Wierer M; Wolf D; Gögenur I; Theander TG; Al-Nakouzi N; Gustavsson T; Daugaard M; Salanti A
    Nat Commun; 2024 Aug; 15(1):7553. PubMed ID: 39215044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Lipopolysaccharide and Interleukin-6 as Useful Screening Tool for Chronic Endometritis.
    Yoneda E; Kim S; Tomita K; Minase T; Kayano M; Watanabe H; Tetsuka M; Sasaki M; Iwayama H; Sanai H; Muranishi Y
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal plasma syndecan-1: a biomarker for fetal growth restriction.
    Juusela A; Jung E; Gallo DM; Bosco M; Suksai M; Diaz-Primera R; Tarca AL; Than NG; Gotsch F; Romero R; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2150074. PubMed ID: 36597808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroitin Sulfate Targeting Nanodrug Achieves Near-Infrared Fluorescence-Guided Chemotherapy Against Triple-Negative Breast Primary and Lung Metastatic Cancer.
    Huang C; Li C; Cai J; Chen J; Wang B; Li M; Zhou W; Wang J; Zhang P; Zhang JV
    Int J Nanomedicine; 2022; 17():5547-5563. PubMed ID: 36444194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas.
    Oravecz O; Balogh A; Romero R; Xu Y; Juhasz K; Gelencser Z; Xu Z; Bhatti G; Pique-Regi R; Peterfia B; Hupuczi P; Kovalszky I; Murthi P; Tarca AL; Papp Z; Matko J; Than NG
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-1 Promotes Angiogenesis in Triple-Negative Breast Cancer through the Prognostically Relevant Tissue Factor Pathway and Additional Angiogenic Routes.
    Nassar E; Hassan N; El-Ghonaimy EA; Hassan H; Abdullah MS; Rottke TV; Kiesel L; Greve B; Ibrahim SA; Götte M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34066023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of rVAR2-Based Isolation of Cancer Cells in Blood for Building a Robust Assay for Clinical Detection of Circulating Tumor Cells.
    Sand NT; Petersen TB; Bang-Christensen SR; Ahrens TD; Løppke C; Jørgensen AM; Gustavsson T; Choudhary S; Theander TG; Salanti A; Agerbæk MØ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and anatomical aspects of the reproduction of mice with reduced Syndecan-1 expression.
    Gougoula C; Bielfeld AP; Pour SJ; Krüssel JS; Götte M; Benten WPM; Baston-Büst DM
    Reprod Biol Endocrinol; 2019 Mar; 17(1):28. PubMed ID: 30825879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-1 Acts as an Important Regulator of CXCL1 Expression and Cellular Interaction of Human Endometrial Stromal and Trophoblast Cells.
    Baston-Buest DM; Altergot-Ahmad O; Pour SJ; Krüssel JS; Markert UR; Fehm TN; Bielfeld AP
    Mediators Inflamm; 2017; 2017():8379256. PubMed ID: 28293067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental Sequestration of Plasmodium falciparum Malaria Parasites Is Mediated by the Interaction Between VAR2CSA and Chondroitin Sulfate A on Syndecan-1.
    Ayres Pereira M; Mandel Clausen T; Pehrson C; Mao Y; Resende M; Daugaard M; Riis Kristensen A; Spliid C; Mathiesen L; E Knudsen L; Damm P; G Theander T; R Hansson S; A Nielsen M; Salanti A
    PLoS Pathog; 2016 Aug; 12(8):e1005831. PubMed ID: 27556547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.